Mon, March 11, 2024
[ 12:00 AM ] - WOPRAI
Thu, December 14, 2023
[ 12:00 AM ] - WOPRAI
Tue, December 12, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, July 14, 2023
[ 12:00 AM ] - WOPRAI
Fri, June 23, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 9, 2023
[ 12:00 AM ] - WOPRAI
Tue, April 4, 2023
[ 12:00 AM ] - WOPRAI
Tue, March 14, 2023
[ 12:00 AM ] - WOPRAI
Wed, March 1, 2023
[ 12:00 AM ] - WOPRAI
Tue, February 28, 2023
[ 12:00 AM ] - WOPRAI
Tue, January 31, 2023
[ 12:00 AM ] - WOPRAI
Mon, January 9, 2023
[ 12:00 AM ] - WOPRAI
Thu, November 10, 2022
[ 12:00 AM ] - WOPRAI
Mon, October 3, 2022
[ 12:00 AM ] - WOPRAI
Thu, September 8, 2022
[ 12:00 AM ] - WOPRAI
Thu, September 1, 2022
[ 12:00 AM ] - WOPRAI
Mon, August 8, 2022
[ 12:00 AM ] - WOPRAI
Fri, August 5, 2022
[ 12:00 AM ] - WOPRAI
Mon, July 11, 2022
[ 12:00 AM ] - WOPRAI
Wed, July 6, 2022
[ 12:00 AM ] - WOPRAI
Wed, June 22, 2022
[ 12:00 AM ] - WOPRAI
Tue, June 14, 2022
[ 12:00 AM ] - WOPRAI
Wed, May 25, 2022
[ 12:00 AM ] - WOPRAI
Tue, May 17, 2022
[ 12:00 AM ] - WOPRAI
Fri, February 25, 2022
[ 12:00 AM ] - WOPRAI
Wed, January 5, 2022
Neena Bitritto-Garg Maintained (AMLX) at Strong Buy with Decreased Target to $8 on, Mar 11th, 2024
Neena Bitritto-Garg of Deutsche Bank, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy with Decreased Target from $36 to $8 on, Mar 11th, 2024.
Neena has made no other calls on AMLX in the last 4 months.
There are 2 other peers that have a rating on AMLX. Out of the 2 peers that are also analyzing AMLX, 1 agrees with Neena's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Umer Raffat of "Evercore ISI Group" Downgraded from Buy to Hold on, Friday, March 8th, 2024
This is the rating of the analyst that currently disagrees with Neena
- Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy with Increased Target to $32 on, Friday, March 8th, 2024
Contributing Sources